Moderna's disclosure about single-shot vaccine booster for Covid-19, flu pushes its shares up
Drug-maker giant Moderna shares surged on Thursday after teh company announced it’s developing a two-in-one vaccine booster shot that protects against both Covid-19 and the seasonal flu.


The new vaccine, which the company is calling mRNA-1073, combines Moderna’s current Covid vaccine with a flu shot that’s also under development, according to a press release. Shares of Moderna jumped by more than 5% after the announcement.
“Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19 and a booster against flu,” CEO Stephane Bancel said in a statement Thursday. “We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalized cancer vaccine trial. We believe this is just the beginning of a new age of information-based medicines.”
The announcement comes on the heels of Moderna’s highly successful launch of its mRNA-based two-dose Covid vaccine, which was authorized for emergency use by the Food and Drug Administration in December. More than 147 million of the Moderna shots have been administered in the U.S., according to data compiled by the Centers for Disease Control and Prevention.
Messenger RNA, or mRNA, technology has been under development for years, but Moderna’s and Pfizer’s vaccines are the first time mRNA has been cleared for use in humans. The mRNA-based Covid vaccines work by tricking the body to produce a harmless piece of the virus, triggering an immune response. It’s said to be easier to produce than traditional vaccines, which generally use a dead or weakened virus to produce an immune response.
Bancel previously said the company hoped to have a booster shot that would combine protection against both viruses.
“What we’re trying to do at Moderna actually is to get a flu vaccine in the clinic this year and then combine our flu vaccine to our Covid vaccine so you only have to get one boost at your local CVS store ... every year that would protect you to the variant of concern against Covid and the seasonal flu strain,” Bancel said in April.
Moderna also announced Thursday it is developing a pediatric vaccine, called mRNA-1365, which would combine vaccines for respiratory syncytial virus and human metapneumovirus.
SOURCE: CNBC

NationalGrid plans Rs100bn Sukuk programme to strengthen Pakistan’s electricity transmission network
- 19 hours ago

The US has officially lost control of measles
- a day ago

CDF munir vows to eliminate menace of terrorism in KP
- 20 hours ago

What makes Americans feel financially ready to have kids? It’s complicated.
- 6 hours ago

Gold prices record visible decline in Pakistan, global markets
- 18 hours ago

The Apple Watch Series 12 is cheaper than ever ahead of Black Friday
- a day ago

Scoop up three great 4K Blu-ray movies for $33
- 8 hours ago

The case for new Democratic leadership
- a day ago

Pakistan clinches Blind T20 Asia Cup title in Dhaka
- 16 hours ago

Trump’s looming nominations crunch
- 21 hours ago

US data centers now burn more electricity than a midsized country
- a day ago

In Yemen's Aden, divided government forces prepare for a Houthi assault
- 14 hours ago













